2020 Form 10-K Financial Statement
#000156459021014676 Filed on March 23, 2021
Income Statement
Concept | 2020 | 2019 Q4 | 2019 |
---|---|---|---|
Revenue | $19.54M | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $15.18M | $2.780M | $9.950M |
YoY Change | 52.56% | 78.21% | 113.06% |
% of Gross Profit | |||
Research & Development | $39.70M | $8.540M | $34.32M |
YoY Change | 15.67% | 12.66% | 8.09% |
% of Gross Profit | |||
Depreciation & Amortization | $1.381M | $330.0K | $1.245M |
YoY Change | 10.92% | 22.22% | 40.52% |
% of Gross Profit | |||
Operating Expenses | $54.88M | $11.32M | $44.27M |
YoY Change | 23.97% | 23.94% | 39.44% |
Operating Profit | -$35.34M | -$44.27M | |
YoY Change | -20.16% | ||
Interest Expense | $850.0K | $540.0K | $2.290M |
YoY Change | -62.88% | -5.26% | 15.08% |
% of Operating Profit | |||
Other Income/Expense, Net | $849.0K | $0.00 | $2.296M |
YoY Change | -63.02% | 10.86% | |
Pretax Income | -$34.50M | -$10.78M | -$41.98M |
YoY Change | -17.82% | 25.93% | 22.21% |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | |||
Net Earnings | -$34.50M | -$10.78M | -$41.98M |
YoY Change | -17.82% | 25.92% | 22.21% |
Net Earnings / Revenue | -176.55% | ||
Basic Earnings Per Share | -$1.40 | ||
Diluted Earnings Per Share | -$1.396M | -$531.0K | -$3.358M |
COMMON SHARES | |||
Basic Shares Outstanding | 24.72M | 20.33M | |
Diluted Shares Outstanding | 24.72M |
Balance Sheet
Concept | 2020 | 2019 Q4 | 2019 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $283.6M | $99.00M | $99.00M |
YoY Change | 186.46% | 10.0% | |
Cash & Equivalents | $72.00M | $34.07M | $34.10M |
Short-Term Investments | $211.5M | $64.90M | $64.90M |
Other Short-Term Assets | $3.100M | $2.700M | $2.700M |
YoY Change | 14.81% | 285.71% | |
Inventory | |||
Prepaid Expenses | |||
Receivables | $1.900M | ||
Other Receivables | $0.00 | ||
Total Short-Term Assets | $288.6M | $101.7M | $101.7M |
YoY Change | 183.78% | 12.12% | 12.13% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $9.500M | $4.642M | $9.700M |
YoY Change | -2.06% | -9.9% | 86.54% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $1.500M | $1.500M | |
YoY Change | |||
Other Assets | $200.0K | $16.00K | $100.0K |
YoY Change | 100.0% | -65.22% | -85.71% |
Total Long-Term Assets | $9.700M | $11.35M | $11.30M |
YoY Change | -14.16% | 93.17% | 94.83% |
TOTAL ASSETS | |||
Total Short-Term Assets | $288.6M | $101.7M | $101.7M |
Total Long-Term Assets | $9.700M | $11.35M | $11.30M |
Total Assets | $298.3M | $113.0M | $113.0M |
YoY Change | 163.98% | 17.05% | 17.1% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.000M | $709.0K | $700.0K |
YoY Change | 42.86% | -49.96% | -50.0% |
Accrued Expenses | $10.10M | $5.023M | $6.200M |
YoY Change | 62.9% | 40.19% | 72.22% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $38.60M | $6.940M | $6.900M |
YoY Change | 459.42% | 28.21% | 27.78% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $61.40M | $34.00K | $5.700M |
YoY Change | 977.19% | -69.91% | 235.29% |
Total Long-Term Liabilities | $61.40M | $34.00K | $5.700M |
YoY Change | 977.19% | -69.91% | 235.29% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $38.60M | $6.940M | $6.900M |
Total Long-Term Liabilities | $61.40M | $34.00K | $5.700M |
Total Liabilities | $100.0M | $12.60M | $12.60M |
YoY Change | 693.65% | 77.53% | 77.46% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$92.49M | ||
YoY Change | 83.09% | ||
Common Stock | $192.8M | ||
YoY Change | 11959.16% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $198.3M | $100.4M | $100.4M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $298.3M | $113.0M | $113.0M |
YoY Change | 163.98% | 17.05% | 17.1% |
Cashflow Statement
Concept | 2020 | 2019 Q4 | 2019 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$34.50M | -$10.78M | -$41.98M |
YoY Change | -17.82% | 25.92% | 22.21% |
Depreciation, Depletion And Amortization | $1.381M | $330.0K | $1.245M |
YoY Change | 10.92% | 22.22% | 40.52% |
Cash From Operating Activities | $55.46M | -$8.700M | -$39.31M |
YoY Change | -241.08% | 16.31% | 42.34% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $493.0K | -$210.0K | $1.353M |
YoY Change | -63.56% | -32.26% | -20.78% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$145.8M | $4.110M | $3.620M |
YoY Change | -4126.24% | -40.35% | -105.89% |
Cash From Investing Activities | -$146.2M | $3.890M | $2.265M |
YoY Change | -6556.64% | -40.88% | -103.59% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $100.7M | $50.32M | |
YoY Change | 100.04% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 128.8M | 40.00K | 50.61M |
YoY Change | 154.4% | -150.0% | -51.97% |
NET CHANGE | |||
Cash From Operating Activities | 55.46M | -8.700M | -39.31M |
Cash From Investing Activities | -146.2M | 3.890M | 2.265M |
Cash From Financing Activities | 128.8M | 40.00K | 50.61M |
Net Change In Cash | 37.97M | -4.770M | 13.56M |
YoY Change | 179.97% | 386.73% | -6.98% |
FREE CASH FLOW | |||
Cash From Operating Activities | $55.46M | -$8.700M | -$39.31M |
Capital Expenditures | $493.0K | -$210.0K | $1.353M |
Free Cash Flow | $54.97M | -$8.490M | -$40.67M |
YoY Change | -235.17% | 18.41% | 38.66% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2019Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
63000 | |
CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6940000 | |
CY2020Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
1877000 | |
CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2698000 | |
CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
101654000 | |
CY2019Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
106000 | |
CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4642000 | |
CY2019Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
5057000 | |
CY2019Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
16000 | |
CY2019Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
1526000 | |
CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
709000 | |
CY2019Q4 | us-gaap |
Assets
Assets
|
113001000 | |
CY2020 | us-gaap |
Operating Expenses
OperatingExpenses
|
54882000 | |
CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-35344000 | |
CY2019 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-44271000 | |
CY2020 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
849000 | |
CY2019Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
5023000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
27613000 | |
CY2019Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1145000 | |
CY2019 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2296000 | |
CY2018 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2071000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-34495000 | |
CY2019 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-41975000 | |
CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-34346000 | |
CY2019 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1353000 | |
CY2018 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1708000 | |
CY2020 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
242314000 | |
CY2019 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
88004000 | |
CY2018 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
133301000 | |
CY2020 | idya |
Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
|
96564000 | |
CY2019 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
96000 | |
CY2018 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-30000 | |
CY2020 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
83773000 | |
CY2018 | us-gaap |
Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
|
-97000 | |
CY2020 | idya |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-49000 | |
CY2019 | idya |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-1249000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
55463000 | |
CY2019 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-39313000 | |
CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-27620000 | |
CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
493000 | |
CY2018 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-34376000 | |
CY2018 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
28000 | |
CY2018 | idya |
Adjustments To Additional Paid In Capital Vesting Of Early Exercise Of Shares
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseOfShares
|
189000 | |
CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
950000 | |
CY2018 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-30000 | |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-48948000 | |
CY2019 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
138391000 | |
CY2020 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1202000 | |
CY2020 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
326000 | |
CY2020 | idya |
Adjustments To Additional Paid In Capital Vesting Of Early Exercise Of Shares
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseOfShares
|
56000 | |
CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3609000 | |
CY2020 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-58000 | |
CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
-34495000 | |
CY2019 | us-gaap |
Profit Loss
ProfitLoss
|
-41975000 | |
CY2018 | us-gaap |
Profit Loss
ProfitLoss
|
-34346000 | |
CY2020 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1381000 | |
CY2019 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1245000 | |
CY2018 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
886000 | |
CY2020 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-578000 | |
CY2019 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
473000 | |
CY2018 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
808000 | |
CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3609000 | |
CY2019 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2168000 | |
CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
950000 | |
CY2018 | idya |
Issuance Of Temporary Equity Stock Pursuant To License Agreement
IssuanceOfTemporaryEquityStockPursuantToLicenseAgreement
|
3812000 | |
CY2018 | idya |
Change In Fair Value Of Redeemable Convertible Preferred Stock Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockLiability
|
70000 | |
CY2018 | idya |
Landlord Contributions For Leasehold Improvements
LandlordContributionsForLeaseholdImprovements
|
367000 | |
CY2020 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-2000 | |
CY2019 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-14000 | |
CY2018 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
54000 | |
CY2020 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
18000 | |
CY2019 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
8000 | |
CY2018 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
11000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1877000 | |
CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
510000 | |
CY2019 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1963000 | |
CY2018 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
243000 | |
CY2020 | idya |
Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
|
148000 | |
CY2019 | idya |
Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
|
-1093000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
225000 | |
CY2019 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-195000 | |
CY2018 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
322000 | |
CY2020 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
2992000 | |
CY2019 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
2030000 | |
CY2018 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1672000 | |
CY2018 | idya |
Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
|
65830000 | |
CY2019 | idya |
Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
|
18094000 | |
CY2018 | idya |
Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
|
6000000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-146243000 | |
CY2019 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
2265000 | |
CY2018 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-63179000 | |
CY2019 | idya |
Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
|
73528000 | |
CY2018 | us-gaap |
Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
|
105358000 | |
CY2019Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
106000 | |
CY2018Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
106000 | |
CY2020 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
100664000 | |
CY2019 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
50321000 | |
CY2020 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
19988000 | |
CY2020 | idya |
Proceeds From Issuance Of Common Stock Related To At Market Offering Program Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockRelatedToAtMarketOfferingProgramNetOfIssuanceCosts
|
6582000 | |
CY2020 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1190000 | |
CY2018 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
71000 | |
CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
105378000 | |
CY2019 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
13562000 | |
CY2018 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
14579000 | |
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6032000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
72143000 | |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
20505000 | |
CY2020Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
106000 | |
CY2020 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1000 | |
CY2019 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1000 | |
CY2018 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1000 | |
CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
82000 | |
CY2019 | us-gaap |
Interest Paid Net
InterestPaidNet
|
91000 | |
CY2018 | us-gaap |
Interest Paid Net
InterestPaidNet
|
99000 | |
CY2020 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
1191000 | |
CY2018 | idya |
Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
|
499000 | |
CY2020 | idya |
Vesting Of Early Exercised Options And Restricted Stock
VestingOfEarlyExercisedOptionsAndRestrictedStock
|
56000 | |
CY2019 | idya |
Vesting Of Early Exercised Options And Restricted Stock
VestingOfEarlyExercisedOptionsAndRestrictedStock
|
114000 | |
CY2018 | idya |
Vesting Of Early Exercised Options And Restricted Stock
VestingOfEarlyExercisedOptionsAndRestrictedStock
|
189000 | |
CY2020 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
520000 | |
CY2018 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
604000 | |
CY2018 | idya |
Extinguishment Of Redeemable Convertible Preferred Stock Liability
ExtinguishmentOfRedeemableConvertiblePreferredStockLiability
|
3137000 | |
CY2019 | idya |
Conversion Of Redeemable Convertible Preferred Stock In To Common Stock
ConversionOfRedeemableConvertiblePreferredStockInToCommonStock
|
138391000 | |
CY2020 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates include useful lives of property and equipment, determination of the discount rate for operating leases, accruals for research and development activities, revenue recognition, stock-based compensation, and income taxes. On an ongoing basis, management reviews these estimates and assumptions. Changes in facts and circumstances may alter such estimates and actual results could differ from those estimates.</p> | |
CY2020 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents, marketable securities and accounts receivable. Substantially all the Company’s cash is held by one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s investment policy addresses credit ratings, diversification, and maturity dates. The Company invests its cash equivalents and marketable securities in money market funds, U.S. government securities, commercial paper, and corporate bonds. The Company limits its credit risk associated with cash equivalents and marketable securities by placing them with banks and institutions it believes are highly creditworthy and in highly rated investments and, by policy, limits the amount of credit exposure with any one commercial issuer. The Company has not experienced any credit losses on its deposits of cash, cash equivalents or marketable securities. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable represents amounts due from GlaxoSmithKline. The Company monitors economic conditions to identify facts or circumstances that may indicate that any of its accounts receivable are at risk of collection.</p> | |
CY2020 | us-gaap |
Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
|
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability is measured by comparison of the carrying amount of the asset or asset group to the future net cash flows which the asset or asset group is expected to generate. If such asset or asset group is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset or asset group exceeds the fair value of the asset or asset group. There have been no such impairments of long-lived assets for the years ended December 31, 2020 and December 31, 2019. </p> | |
CY2020Q4 | idya |
Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
|
283600000 | |
CY2019Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.0975 | |
CY2020 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
CY2020 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
CY2020 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
CY2019 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
216541000 | |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
21000 | |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
14000 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
216548000 | |
CY2020Q4 | us-gaap |
Investment Owned At Cost
InvestmentOwnedAtCost
|
283606000 | |
CY2020Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
283613000 | |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
66350000 | |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
69000 | |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
4000 | |
CY2019Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
66415000 | |
CY2019Q4 | us-gaap |
Investment Owned At Cost
InvestmentOwnedAtCost
|
100358000 | |
CY2019Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
100423000 | |
CY2020Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
0 | |
CY2019Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
0 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
8165000 | |
CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7158000 | |
CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3894000 | |
CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2516000 | |
CY2020 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1400000 | |
CY2019 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1200000 | |
CY2018 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
900000 | |
CY2020Q4 | idya |
Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
|
5259000 | |
CY2019Q4 | idya |
Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
|
2787000 | |
CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2685000 | |
CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1733000 | |
CY2020Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
543000 | |
CY2019Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
457000 | |
CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
29000 | |
CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
46000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
1930000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
1982000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
2036000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
1647000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
7595000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
872000 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
-0.004 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
-0.013 | |
CY2020Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
6723000 | |
CY2020 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
1500000 | |
CY2019 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
1500000 | |
CY2020 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1700000 | |
CY2019 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1700000 | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2019 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2018 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.019 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.070 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.069 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.215 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.314 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.294 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.027 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.036 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.027 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
-0.003 | |
CY2020 | idya |
Effective Income Tax Rate Reconciliation Change In Fair Value Of Redeemable Convertible Preferred Stock Liability
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfRedeemableConvertiblePreferredStockLiability
|
0.000 | |
CY2019 | idya |
Effective Income Tax Rate Reconciliation Change In Fair Value Of Redeemable Convertible Preferred Stock Liability
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfRedeemableConvertiblePreferredStockLiability
|
0.002 | |
CY2018 | idya |
Effective Income Tax Rate Reconciliation Change In Fair Value Of Redeemable Convertible Preferred Stock Liability
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfRedeemableConvertiblePreferredStockLiability
|
0.001 | |
CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | |
CY2019 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | |
CY2018 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
13418000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
23947000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
3813000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
2995000 | |
CY2020Q4 | idya |
Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
|
1420000 | |
CY2019Q4 | idya |
Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
|
1895000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
1274000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
1809000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
705000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
407000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
505000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
436000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
17332000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
38467000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
31489000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
36879000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
29462000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
1588000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
2027000 | |
CY2020Q4 | idya |
Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
|
1100000 | |
CY2019Q4 | idya |
Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
|
1415000 | |
CY2020Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
488000 | |
CY2019Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
612000 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
901000 | |
CY2019Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
746000 | |
CY2018Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
399000 | |
CY2019 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
59000 | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
153000 | |
CY2020 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
Each share of common stock is entitled to one vote. | |
CY2019 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
288000 | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
2000 | |
CY2020Q4 | idya |
Number Of Common Stock Voting Rights Held Per Share
NumberOfCommonStockVotingRightsHeldPerShare
|
1 | |
CY2020 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
0 | |
CY2019Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
3194078 | |
CY2019 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2168000 | |
CY2018 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
950000 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
6.16 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
6.73 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
1700000 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
800000 | |
CY2020Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
8500000 | |
CY2020 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
10518 | |
CY2019 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
23698 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.849 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.772 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.803 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
0.983 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
0.855 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
0.823 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.003 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.014 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.026 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.015 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.025 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.031 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2020 | idya |
Collaboration Revenue
CollaborationRevenue
|
19538000 | |
CY2020Q4 | us-gaap |
Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
|
1900000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
83800000 | |
CY2020 | idya |
Receipt Of Upfront Payments
ReceiptOfUpfrontPayments
|
100000000 | |
CY2020 | us-gaap |
Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
|
19538000 | |
CY2020 | idya |
Cash Received For Cost Reimbursement
CashReceivedForCostReimbursement
|
1434000 | |
CY2020 | idya |
Gross Increase In Accounts Receivable During Period
GrossIncreaseInAccountsReceivableDuringPeriod
|
1877000 | |
CY2020 | idya |
Reimbursement Period Of Costs Incurred
ReimbursementPeriodOfCostsIncurred
|
P75D | |
CY2020 | idya |
Number Of Additional Customer Options
NumberOfAdditionalCustomerOptions
|
2 | |
CY2020Q4 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
89291000 | |
CY2020 | idya |
Weighted Average Number Of Shares Issued Basic And Diluted
WeightedAverageNumberOfSharesIssuedBasicAndDiluted
|
24783287 | |
CY2019 | idya |
Weighted Average Number Of Shares Issued Basic And Diluted
WeightedAverageNumberOfSharesIssuedBasicAndDiluted
|
12669367 | |
CY2018 | idya |
Weighted Average Number Of Shares Issued Basic And Diluted
WeightedAverageNumberOfSharesIssuedBasicAndDiluted
|
1338776 | |
CY2020 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
61512 | |
CY2019 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
172410 | |
CY2018 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
382524 | |
CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2620541 | |
CY2019 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2061921 | |
CY2018 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14996003 | |
CY2020 | us-gaap |
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
|
0.90 | |
CY2020 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
200000 | |
CY2019 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
200000 | |
CY2020 | us-gaap |
Defined Contribution Plan Plan Name Extensible List
DefinedContributionPlanPlanNameExtensibleList
|
idya:FourZeroOneKPlanMember | |
CY2019 | us-gaap |
Defined Contribution Plan Plan Name Extensible List
DefinedContributionPlanPlanNameExtensibleList
|
idya:FourZeroOneKPlanMember | |
CY2020Q4 | us-gaap |
Defined Contribution Plan Sponsor Location Extensible List
DefinedContributionPlanSponsorLocationExtensibleList
|
country:US | |
CY2019Q4 | us-gaap |
Defined Contribution Plan Sponsor Location Extensible List
DefinedContributionPlanSponsorLocationExtensibleList
|
country:US | |
CY2020Q4 | us-gaap |
Defined Contribution Plan Tax Status Extensible List
DefinedContributionPlanTaxStatusExtensibleList
|
us-gaap:QualifiedPlanMember | |
CY2019Q4 | us-gaap |
Defined Contribution Plan Tax Status Extensible List
DefinedContributionPlanTaxStatusExtensibleList
|
us-gaap:QualifiedPlanMember |